The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Waiting Lists

 Llovet,  Mas,  Aponte,  Fuster,  Navasa,  Christensen,  Rodés,  Bruix,  Häkkinen,  Neva,  Kauppi,  Hannonen,  Ylinen,  Mäkinen,  Jäppinen,  Sokka,  Everson,  Oton-Nieto,  Barcena-Marugan,  Carrera-Alonso,  Blesa-Radigales,  Garcia-Gonzalez,  Nuño,  Plaza-Palacios,  Garcia-Plaza,  Brandsaeter,  Broomé,  Isoniemi,  Friman,  Hansen,  Schrumpf,  Oksanen,  Ericzon,  Höckerstedt,  Mäkisalo,  Olsson,  Olausson,  Kirkegaard,  Bjøro,  Furmark,  Tillfors,  Marteinsdottir,  Fischer,  Pissiota,  Långström,  Fredrikson,  Böhringer,  Reinhard,  Duquesnoy,  Böhringer,  Enczmann,  Lange,  Claas,  Sundmacher,  Schwartz,  Zand,  Bose,  Vo,  Coppage,  Pellegrin,  Arend,  Lee,  Bozorgzadeh,  Leong,  Azeka,  Franchini Ramires,  Valler,  Alcides Bocchi,  Button,  Roberts,  Kotsimbos,  Levvey,  Williams,  Bailey,  Snell,  Wilson,  Pereira,  Natov,  Bouthot,  Murthy,  Ruthazer,  Schmid,  Levey,  West,  Pollock-Barziv,  Dipchand,  Lee,  Cardella,  Benson,  Rebeyka,  Coles,  van Minnen,  Hoogduin,  Keijsers,  Hellenbrand,  Hendriks,  Schwartz,  Highfield,  Jaffe,  Brady,  Butler,  Rouse,  Callaman,  O'Grady,  Battjes,  Böhringer,  Reinhard,  Böhringer,  Enczmann,  Godehard,  Sundmacher,  Emery,  Schein,  Hauck,  MacIntyre,  Abbott,  Hypolite,  Agodoa,  Sauer,  Kraus,  Schemmer,  Mehrabi,  Stremmel,  Buechler,  Encke,  Bolondi,  Piscaglia,  Camaggi,  Grazi,  Cavallari,  Myles,  Leslie,  Angliss,  Mezzavia,  Lee,  
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Waiting Lists


Psychiatry related information on Waiting Lists


High impact information on Waiting Lists

  • Because of the use of ABO-incompatible donors, the mortality rate among infants on the waiting list declined from 58 percent to 7 percent [11].
  • Patients with 1 HCC nodule </=5 cm in diameter, or 2-3 nodules </=3cm, receive United Network Organ Sharing priority; nevertheless, dropout from the waiting list is common [12].
  • OBJECTIVE: To compare the effectiveness of interim methadone maintenance with that of the usual waiting list condition in facilitating methadone treatment entry and reducing heroin and cocaine use and criminal behavior [13].
  • RESULTS: Symptoms improved significantly and roughly equally with citalopram and cognitive-behavioral therapy, whereas the waiting-list group remained unchanged [14].
  • Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment [15].

Chemical compound and disease context of Waiting Lists


Biological context of Waiting Lists


Anatomical context of Waiting Lists

  • Monocyte cytotoxic crossmatches were performed on the sera of all 164 patients on the Victorian transplant waiting list in order to determine the incidence of antimonocyte antibodies and to assess if prospective screening for these antibodies would be justified [25].
  • We further analyzed T- and B-cell responses in 14 patients on the renal transplant waiting list, finding that those with an elevated panel reactive antibody (PRA) (>60%) had higher alloreactive T-cell precursor frequencies as measured by CDFSE MLR and IFN-gamma ELISPOT [26].

Associations of Waiting Lists with chemical compounds

  • RESULTS: Significantly more participants assigned to the interim methadone maintenance condition entered comprehensive methadone maintenance treatment by the 120th day from baseline (75.9%) than those assigned to the waiting list control condition (20.8%) (P<.001) [13].
  • Dropout from the waiting list is common and several methods, including percutaneous ethanol injection, radiofrequency ablation, and chemoembolization, are used to prevent tumor progression and thus prevent dropout [27].
  • Fewer patients receiving MMT retained a spot on the transplant waiting list (65%) than patients not receiving MMT (80%); 30% of patients receiving MMT pretransplant used heroin, cocaine, or marijuana, and more than 25% were lost to follow-up [28].
  • Review article: liver transplantation for HCC. Treatment options on the waiting list [29].
  • In patients listed for LT before initiation of prostacyclin therapy, 55% (12/22) were removed from the active waiting list for 27.2+/-17 months (range 8 to 60), and 92% (11/12) remain on the inactive status [30].

Gene context of Waiting Lists

  • Reduction of time on the waiting list as compared to conventional HLA-A and HLA-B matching was predicted individually [31].
  • For a waiting-list group of nine children with ADHD, the same testing was applied [32].
  • Application of a continuous disease severity score to the OPTN liver waiting list [33].
  • Adults with CF on the waiting list and after LTx were prospectively recruited [34].
  • This study examined the effect of exercise and education on 79 older adults (M age = 66.6 +/- 6.5 years; 53% female) with COPD, randomly assigned to 10 weeks of (a) exercise, education, and stress management (EXESM; n = 29); (b) education and stress management (ESM; n = 25); or (c) waiting list (WL; n = 25) [35].

Analytical, diagnostic and therapeutic context of Waiting Lists


  1. Predictors of GBV-C infection among patients referred for renal transplantation. Murthy, B.V., Muerhoff, A.S., Desai, S.M., Natov, S.N., Bouthot, B.A., Ruthazer, R., Schmid, C.H., Levey, A.S., Mushahwar, I.K., Pereira, B.J. Kidney Int. (1998) [Pubmed]
  2. Increased levels of GALbeta1-4GLCNACalpha2-6 sialyltransferase pretransplant predict delayed graft function in kidney transplant recipients. Thorne-Tjomsland, G., Hosfield, T., Jamieson, J.C., Liu, B., Nickerson, P., Gough, J.C., Rush, D.N., Jeffery, J.R., McKenna, R.M. Transplantation (2000) [Pubmed]
  3. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Brandsaeter, B., Broomé, U., Isoniemi, H., Friman, S., Hansen, B., Schrumpf, E., Oksanen, A., Ericzon, B.G., Höckerstedt, K., Mäkisalo, H., Olsson, R., Olausson, M., Kirkegaard, P., Bjøro, K. Liver Transpl. (2003) [Pubmed]
  4. Can a surgical treatment centre reduce waiting lists? Results of a natural experiment. Harvey, I., Webb, M., Dowse, J. Journal of epidemiology and community health. (1993) [Pubmed]
  5. Cost analysis of epilepsy surgery and of vigabatrin treatment in patients with refractory partial epilepsy. Malmgren, K., Hedström, A., Granqvist, R., Malmgren, H., Ben-Menachem, E. Epilepsy Res. (1996) [Pubmed]
  6. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. van Minnen, A., Hoogduin, K.A., Keijsers, G.P., Hellenbrand, I., Hendriks, G.J. Arch. Gen. Psychiatry (2003) [Pubmed]
  7. A controlled comparison of two treatments for nocturnal enuresis. Wagner, W., Johnson, S.B., Walker, D., Carter, R., Wittner, J. J. Pediatr. (1982) [Pubmed]
  8. Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial. Myles, P.S., Leslie, K., Angliss, M., Mezzavia, P., Lee, L. Anaesthesia. (2004) [Pubmed]
  9. Percutaneous transluminal angioplasty for intermittent claudication: evidence on which to base the medicine. Chetter, I.C., Spark, J.I., Kent, P.J., Berridge, D.C., Scott, D.J., Kester, R.C. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. (1998) [Pubmed]
  10. Retention of patients who entered methadone maintenance via an interim methadone clinic. Friedman, P., Des Jarlais, D.C., Peyser, N.P., Nichols, S.E., Drew, E., Newman, R.G. Journal of psychoactive drugs. (1994) [Pubmed]
  11. ABO-incompatible heart transplantation in infants. West, L.J., Pollock-Barziv, S.M., Dipchand, A.I., Lee, K.J., Cardella, C.J., Benson, L.N., Rebeyka, I.M., Coles, J.G. N. Engl. J. Med. (2001) [Pubmed]
  12. Liver transplantation for hepatocellular carcinoma. Schwartz, M. Gastroenterology (2004) [Pubmed]
  13. A randomized controlled trial of interim methadone maintenance. Schwartz, R.P., Highfield, D.A., Jaffe, J.H., Brady, J.V., Butler, C.B., Rouse, C.O., Callaman, J.M., O'Grady, K.E., Battjes, R.J. Arch. Gen. Psychiatry (2006) [Pubmed]
  14. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Furmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Långström, B., Fredrikson, M. Arch. Gen. Psychiatry (2002) [Pubmed]
  15. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. Azeka, E., Franchini Ramires, J.A., Valler, C., Alcides Bocchi, E. J. Am. Coll. Cardiol. (2002) [Pubmed]
  16. Treatment of patients with hepatitis C virus on the waiting list. Everson, G.T. Liver Transpl. (2003) [Pubmed]
  17. Perhexiline maleate in the treatment of angina pectoris in patients awaiting coronary artery bypass surgery. Armstrong, M.L. Current medical research and opinion. (1976) [Pubmed]
  18. A note on behavioural treatment in the rehabilitation of myocardial infarction patients. Fielding, R. The British journal of social and clinical psychology. (1980) [Pubmed]
  19. Variability of MELD score during the year before liver transplantation. Oton-Nieto, E., Barcena-Marugan, R., Carrera-Alonso, E., Blesa-Radigales, C., Garcia-Gonzalez, M., Nuño, J., Plaza-Palacios, G., Garcia-Plaza, A. Transplant. Proc. (2005) [Pubmed]
  20. Analysis of the renal transplant waiting list: application of a parametric competing risk method. Smits, J.M., van Houwelingen, H.C., De Meester, J., Persijn, G.G., Claas, F.H. Transplantation (1998) [Pubmed]
  21. Predicting time on the waiting list for HLA matched corneal grafts. Böhringer, D., Reinhard, T., Böhringer, S., Enczmann, J., Godehard, E., Sundmacher, R. Tissue Antigens (2002) [Pubmed]
  22. Treatment-independent pregnancy rate in patients with severe reproductive disorders. Evers, J.L., de Haas, H.W., Land, J.A., Dumoulin, J.C., Dunselman, G.A. Hum. Reprod. (1998) [Pubmed]
  23. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Abbott, K.C., Hypolite, I.O., Agodoa, L.Y. Clin. Nephrol. (2002) [Pubmed]
  24. Decreased muscle strength and mobility of the neck in patients with rheumatoid arthritis and atlantoaxial disorders. Häkkinen, A., Neva, M.H., Kauppi, M., Hannonen, P., Ylinen, J., Mäkinen, H., Jäppinen, I., Sokka, T. Archives of physical medicine and rehabilitation. (2005) [Pubmed]
  25. The incidence of antimonocyte alloantibodies. Evidence that prospective crossmatching is unnecessary. O'Connell, P.J., McKenzie, A., Tait, B.D., d'Apice, A.J. Transplantation (1990) [Pubmed]
  26. A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity. Zand, M.S., Bose, A., Vo, T., Coppage, M., Pellegrin, T., Arend, L., Lee, F.E., Bozorgzadeh, A., Leong, N. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. (2005) [Pubmed]
  27. Liver transplantation for hepatocellular carcinoma: is there evidence for expanding the selection criteria? Sauer, P., Kraus, T.W., Schemmer, P., Mehrabi, A., Stremmel, W., Buechler, M.W., Encke, J. Transplantation (2005) [Pubmed]
  28. A matched comparison study of medical and psychiatric complications and anesthesia and analgesia requirements in methadone-maintained liver transplant recipients. Weinrieb, R.M., Barnett, R., Lynch, K.G., DePiano, M., Atanda, A., Olthoff, K.M. Liver Transpl. (2004) [Pubmed]
  29. Review article: liver transplantation for HCC. Treatment options on the waiting list. Bolondi, L., Piscaglia, F., Camaggi, V., Grazi, G.L., Cavallari, A. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  30. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. Conte, J.V., Gaine, S.P., Orens, J.B., Harris, T., Rubin, L.J. J. Heart Lung Transplant. (1998) [Pubmed]
  31. Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty. Böhringer, D., Reinhard, T., Duquesnoy, R.J., Böhringer, S., Enczmann, J., Lange, P., Claas, F., Sundmacher, R. Transplantation (2004) [Pubmed]
  32. Training of slow cortical potentials in attention-deficit/hyperactivity disorder: evidence for positive behavioral and neurophysiological effects. Heinrich, H., Gevensleben, H., Freisleder, F.J., Moll, G.H., Rothenberger, A. Biol. Psychiatry (2004) [Pubmed]
  33. Application of a continuous disease severity score to the OPTN liver waiting list. Edwards, E.B., Harper, A.M. Clinical transplants. (2001) [Pubmed]
  34. Gastroesophageal reflux (symptomatic and silent): a potentially significant problem in patients with cystic fibrosis before and after lung transplantation. Button, B.M., Roberts, S., Kotsimbos, T.C., Levvey, B.J., Williams, T.J., Bailey, M., Snell, G.I., Wilson, J.W. J. Heart Lung Transplant. (2005) [Pubmed]
  35. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Emery, C.F., Schein, R.L., Hauck, E.R., MacIntyre, N.R. Health psychology : official journal of the Division of Health Psychology, American Psychological Association. (1998) [Pubmed]
  36. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Llovet, J.M., Mas, X., Aponte, J.J., Fuster, J., Navasa, M., Christensen, E., Rodés, J., Bruix, J. Gut (2002) [Pubmed]
  37. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. Schnuelle, P., Lorenz, D., Trede, M., Van Der Woude, F.J. J. Am. Soc. Nephrol. (1998) [Pubmed]
  38. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Glanton, C.W., Kao, T.C., Cruess, D., Agodoa, L.Y., Abbott, K.C. Kidney Int. (2003) [Pubmed]
  39. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Pereira, B.J., Natov, S.N., Bouthot, B.A., Murthy, B.V., Ruthazer, R., Schmid, C.H., Levey, A.S. Kidney Int. (1998) [Pubmed]
  40. Tauroursodeoxycholic acid administration as adjuvant therapy in cirrhotic patients on transplantation waiting lists. Caglieris, S., Giannini, E., Dardano, G., Mondello, L., Valente, U., Testa, R. Hepatogastroenterology (2000) [Pubmed]
WikiGenes - Universities